These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Genital herpes research: many aim to tame maverick virus. Gunby P JAMA; 1983 Nov; 250(18):2417-9, 2423-4, 2427. PubMed ID: 6313974 [No Abstract] [Full Text] [Related]
4. Immunization against genital herpes with a vaccine virus that has defects in productive and latent infection. Da Costa XJ; Jones CA; Knipe DM Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6994-8. PubMed ID: 10359827 [TBL] [Abstract][Full Text] [Related]
7. Herpes simplex virus in pregnancy: new concepts in prevention and management. Hill J; Roberts S Clin Perinatol; 2005 Sep; 32(3):657-70. PubMed ID: 16085025 [TBL] [Abstract][Full Text] [Related]
8. Vaccines against genital herpes: progress and limitations. Morrison LA Drugs; 2002; 62(8):1119-29. PubMed ID: 12010075 [TBL] [Abstract][Full Text] [Related]
9. From the National Institutes of Allergy and Infectious Diseases. Summary of a workshop on antiviral agents for genital herpesvirus infections. Myers MW; Glasgow LA; Galasso GJ J Infect Dis; 1982 May; 145(5):774-82. PubMed ID: 6281343 [No Abstract] [Full Text] [Related]
10. Clinical and serological outcome of genital herpes simplex virus (HSV) type 2 inoculation following oral HSV type 1 infection in guinea-pigs. Bernstein DI; Lee FK; Echler G; Nahmias AJ J Gen Virol; 1989 Sep; 70 ( Pt 9)():2365-72. PubMed ID: 2550572 [TBL] [Abstract][Full Text] [Related]
11. Inactivated Orf-virus shows disease modifying antiviral activity in a guinea pig model of genital herpesvirus infection. Friebe A; Siegling A; Weber O J Microbiol Immunol Infect; 2018 Oct; 51(5):587-592. PubMed ID: 28711432 [TBL] [Abstract][Full Text] [Related]
13. [Indices of the immune status of recurrent herpes patients being treated with a herpes polyvaccine]. Belokrinitskiĭ DV; Karpovich LG; Barinskiĭ IF; Bukovskaia SN; Semenova TB Vopr Virusol; 1987; 32(2):229-33. PubMed ID: 3037800 [TBL] [Abstract][Full Text] [Related]
14. Development of prophylactic vaccines for genital and neonatal herpes. Jones CA; Cunningham AL Expert Rev Vaccines; 2003 Aug; 2(4):541-9. PubMed ID: 14711338 [TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs. Hoshino Y; Dalai SK; Wang K; Pesnicak L; Lau TY; Knipe DM; Cohen JI; Straus SE J Virol; 2005 Jan; 79(1):410-8. PubMed ID: 15596834 [TBL] [Abstract][Full Text] [Related]
16. Impact of immunization with glycoprotein D2/AS04 on herpes simplex virus type 2 shedding into the genital tract in guinea pigs that become infected. Bourne N; Milligan GN; Stanberry LR; Stegall R; Pyles RB J Infect Dis; 2005 Dec; 192(12):2117-23. PubMed ID: 16288376 [TBL] [Abstract][Full Text] [Related]
17. Vaccine induced HSV 1 antibodies fail to correlate with protection against HSV 2 in guinea pigs. Welch MJ; Ridgeway PH; Phillpotts RJ FEMS Microbiol Immunol; 1988 Dec; 1(3):157-62. PubMed ID: 2856207 [TBL] [Abstract][Full Text] [Related]
18. Vaccination strategies to prevent genital herpes and neonatal herpes simplex virus (HSV) disease. Jones CA; Cunningham AL Herpes; 2004 Apr; 11(1):12-7. PubMed ID: 15115632 [TBL] [Abstract][Full Text] [Related]
19. Intramuscular vaccination of guinea pigs with the live-attenuated human herpes simplex vaccine VC2 stimulates a transcriptional profile of vaginal Th17 and regulatory Tr1 responses. Stanfield BA; Rider PJF; Caskey J; Del Piero F; Kousoulas KG Vaccine; 2018 May; 36(20):2842-2849. PubMed ID: 29655629 [TBL] [Abstract][Full Text] [Related]
20. Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease. Da Costa XJ; Bourne N; Stanberry LR; Knipe DM Virology; 1997 May; 232(1):1-12. PubMed ID: 9185583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]